NEW YORK, December 29, 2025, 23:20 ET — Market closed
- Brand Engagement Network shares closed up 108.8% on Monday after disclosing a pharma-focused AI engagement contract.
- The company said it expects $250,000 in Q4 development revenue and anticipates monthly license fees in Q1 2026.
- Traders are watching for deployment timing, follow-on work and the stock’s ability to hold key technical levels.
Brand Engagement Network, Inc shares more than doubled on Monday after the company disclosed a project agreement to develop a custom AI engagement tool tied to an established prescription drug for a top-10 global pharmaceutical client. The company said it expects $250,000 in fourth-quarter development revenue and anticipates monthly license fees starting in the first quarter of 2026; the stock closed up 108.8% at $2.51. 1
The agreement offers a near-term revenue catalyst for a thinly traded AI microcap trying to prove it can turn pilot work into repeatable contracts and recurring software fees. The timing matters with the quarter winding down, when investors focus on what revenue is likely to be recognized and what cash is available to fund operations.
In its latest quarterly report, BEN said its liquidity position raised substantial doubt about its ability to continue as a going concern, with cash and cash equivalents of about $102,715 at Sept. 30. The filing showed revenue of $60,120 for the quarter and $75,120 for the first nine months. 2
BNAI traded between $1.77 and $2.91 on Monday, with volume swelling to about 148.6 million shares versus roughly 149,000 shares on Friday, according to market data. 3
Statements of Work — common contract add-ons — typically spell out the specific deliverables, timelines and acceptance criteria for each phase of a project. License fees are recurring payments for continued use of software once a tool is implemented.
Acting Chief Executive Officer Tyler Luck said the deal “reflects BEN’s progression in healthcare,” calling the company’s AI “trusted, secured, and efficient.” The press release also pointed to the company’s broader push into healthcare initiatives, including work tied to Latin America. 4
Brand Engagement Network develops conversational AI software and human-like AI avatars aimed at customer engagement, according to the company’s investor materials. 5
Investors will be looking for evidence the initial development work converts into recurring fees and expands into additional Statements of Work or similar projects, particularly if the company provides more detail when the solution is formally released.
Before next session, chart watchers will be focused on whether BNAI can hold above the $2.50 area after Monday’s spike. The day’s $1.77 low marks a near-term support level, with the $2.91 intraday high a nearby ceiling if momentum resumes.
A clear date for the company’s next earnings update was not listed on Nasdaq’s earnings page late Monday, leaving traders to rely on company disclosures and future filings for the next scheduled catalyst. 6
In the broader market on Tuesday, investors will track U.S. data including the S&P Case-Shiller home price index and the Chicago PMI, with thin year-end liquidity often amplifying moves in smaller, lower-priced stocks. 7
